Produkty 1044-89-9

CAS 1044-89-9 występuje w naszej ofercie pod nazwami: Cyclic 17-(1,2-Ethanediyl Acetal) Androst-4-ene-3,17-dione, 17,17–(Ethylenedioxy)androst–4–en–3–one, 17,17-(Ethylenedioxy)androst-4-en-3-one, 99.63%. Oferty producentów: TRC, GLPBio, MedChemExpress. Dostępne opakowania: 250mg, 25mg, 100mg, 1 g, 10 g, 10mM/1mL, 500 mg, 100 mg.

Cyclic 17-(1,2-Ethanediyl Acetal) Androst-4-ene-3,17-dione
TRC
  • opakowanie: 250mg, 25mg
  • Warianty: 2
Zobacz produkt
17,17–(Ethylenedioxy)androst–4–en–3–one
GLPBio
  • opakowanie: 100mg
  • Warianty: 1
od 625,12
Zobacz produkt
17,17-(Ethylenedioxy)androst-4-en-3-one, 99.63%
MedChemExpress
  • opakowanie: 1 g, 10 g, 10mM/1mL, 500 mg
  • Warianty: 6
od 361,49
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8'R,9'S,10'R,13'S,14'S)-10',13'-dimethylspiro[1,3-dioxolane-2,17'-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene]-3'-one (CAS 1044-89-9) to związek chemiczny o wzorze sumarycznym C21H30O3 i masie molowej 330.5 g/mol. Nazwa systematyczna IUPAC: (8'R,9'S,10'R,13'S,14'S)-10',13'-dimethylspiro[1,3-dioxolane-2,17'-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene]-3'-one. InChIKey: KFDWIKRQOPJCDM-DEPCRRQNSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O3
Masa molowa330.5 g/mol
Nazwa IUPAC(8'R,9'S,10'R,13'S,14'S)-10',13'-dimethylspiro[1,3-dioxolane-2,17'-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene]-3'-one
InChIKeyKFDWIKRQOPJCDM-DEPCRRQNSA-N
SMILESC[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC45OCCO5)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 17,17-(Ethylenedioxy)androst-4-en-3-one, Androstenedione-17-ethyleneketal, Cyclic 17-(1,2-Ethanediyl Acetal) Androst-4-ene-3,17-dione, orb1692003
Izomery (ten sam wzór sumaryczny)
(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,4,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O3
(1R,2R,4R,5R,7S,10R,11S,14S,16S,18S,19S)-5,7-dihydroxy-10,14-dimethylhexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecan-15-one C21H30O3
(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol C21H30O3
(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O3
methyl (8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-17-carboxylate C21H30O3
[(7R,8R,9S,10R,13S,14S,17S)-7,13-dimethyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C21H30O3
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate C21H30O3
[(1S,2S,4R,6S,8S,11R,12S,16S)-2,16-dimethyl-5-oxapentacyclo[9.7.0.02,8.04,6.012,16]octadec-14-en-15-yl] acetate C21H30O3
(8S,9S,10R,13S,14S,16R,17R)-17-acetyl-16-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O3
(6R,8S,9S,10R,13S,14S,17S)-17-acetyl-6-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O3
(2E,4E,6E,8E)-9-(3-methoxy-2,6,6-trimethylcyclohexen-1-yl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid C21H30O3
(8S,9S,10R,13S,14S,17S)-17-acetyl-6-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O3